Published on: February 10, 2020 at 10:30PM
Condition: Latent Autoimmune Diabetes in Adults
Interventions: Drug: recombinant human glutamic acid dehydrogenase (rhGAD65), formulated in aluminium hydrogel; Drug: Vitamin D
Sponsors: Norwegian University of Science and Technology; St. Olavs Hospital; Diamyd Medical AB; Karolinska University Hospital; Linkoeping University
Not yet recruiting
https://ift.tt/39lvSqY
Monday, 10 February 2020
New diabetes clinical trial: Injections of Glutamic Acid Decarboxylase (GAD) for LADA Type of Diabetes
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.